Kalaris Therapeutics, Inc. (KLRS) › RevenueKalaris Therapeutics, Inc. (KLRS) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2019$165.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share